S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:MKKGY

Merck KGaA (MKKGY) Stock Price, News & Analysis

$35.23
+0.50 (+1.44%)
(As of 03/28/2024 ET)
Today's Range
$35.23
$35.54
50-Day Range
$31.92
$35.25
52-Week Range
$28.59
$38.63
Volume
20,352 shs
Average Volume
75,147 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MKKGY stock logo

About Merck KGaA Stock (OTCMKTS:MKKGY)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KGaA.

MKKGY Stock Price History

MKKGY Stock News Headlines

FDA Greenlights Merck for Lung Treatment
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Merck KGaA ADR MKKGY
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Merck & Company (MRK) Gets a Buy from Cantor Fitzgerald
Merck KGaA (MKGAF) Q4 2023 Earnings Call Transcript
Merck Canada Launches Indigenous Student Scholarship
See More Headlines
Receive MKKGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:MKKGY
CIK
N/A
Fax
N/A
Employees
62,908
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Ms. Belen Garijo Lopez M.D. (Age 64)
    Chair of Executive Board & CEO
    Comp: $7.25M
  • Ms. Helene von Roeder (Age 54)
    CFO & Member of Executive Board
    Comp: $1.35M
  • Dr. Kai Beckmann (Age 59)
    CEO of Electronics & Member of the Executive Board
    Comp: $5.31M
  • Mr. Peter Guenter (Age 62)
    CEO of Healthcare Business & Member of Executive Board
    Comp: $6.11M
  • Dr. Matthias J. Heinzel (Age 57)
    CEO of Life Science Sector & Member of Executive Board
    Comp: $5.72M

MKKGY Stock Analysis - Frequently Asked Questions

Should I buy or sell Merck KGaA stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merck KGaA in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MKKGY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MKKGY, but not buy additional shares or sell existing shares.
View MKKGY analyst ratings
or view top-rated stocks.

How have MKKGY shares performed in 2024?

Merck KGaA's stock was trading at $31.93 on January 1st, 2024. Since then, MKKGY stock has increased by 10.3% and is now trading at $35.23.
View the best growth stocks for 2024 here
.

Are investors shorting Merck KGaA?

Merck KGaA saw a decrease in short interest in March. As of March 15th, there was short interest totaling 3,800 shares, a decrease of 83.5% from the February 29th total of 23,000 shares. Based on an average trading volume of 165,100 shares, the short-interest ratio is presently 0.0 days.
View Merck KGaA's Short Interest
.

How often does Merck KGaA pay dividends? What is the dividend yield for Merck KGaA?

Merck KGaA declared a dividend on Monday, May 1st. Stockholders of record on Wednesday, May 3rd will be paid a dividend of $0.3172 per share on Thursday, May 11th. This represents a dividend yield of 0.87%. The ex-dividend date of this dividend is Tuesday, May 2nd.
Read our dividend analysis for MKKGY
.

How do I buy shares of Merck KGaA?

Shares of MKKGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MKKGY) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners